Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Study to Assess the Clinical Efficacy and Safety of Manuka Eye Drops for Treatment of Allergy

NCT03862053 is registered in ClinicalTrials.gov with Toyos Clinic as lead sponsor.

NCT NCT03862053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03862053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Study to Assess the Clinical Efficacy and Safety of Manuka Eye Drops for Treatment of Allergy
Lead sponsor
Toyos Clinic
Phase
Phase 4
Overall status
Withdrawn
Start date
January 1, 2020
Completion date
October 7, 2020
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis